Cargando…

An Emerging Strategy for Neuroinflammation Treatment: Combined Cannabidiol and Angiotensin Receptor Blockers Treatments Effectively Inhibit Glial Nitric Oxide Release

Cannabidiol (CBD), the major non-psychoactive phytocannabinoid found in cannabis, has anti-neuroinflammatory properties. Despite the increasing use of CBD, little is known about its effect in combination with other substances. Combination therapy has been gaining attention recently, aiming to produc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fleisher-Berkovich, Sigal, Battaglia, Veronica, Baratta, Francesca, Brusa, Paola, Ventura, Yvonne, Sharon, Nitzan, Dahan, Arik, Collino, Massimo, Ben-Shabat, Shimon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671332/ https://www.ncbi.nlm.nih.gov/pubmed/38003444 http://dx.doi.org/10.3390/ijms242216254

Ejemplares similares

Editorial: Medicinal Cannabis: Evolution of therapeutic use, future approaches and other implications
por: Brusa, Paola, et al.
Publicado: (2022)

Editorial: Medicinal Cannabis: evolution of therapeutic use, future approaches and other implications, volume II
por: Baratta, Francesca, et al.
Publicado: (2023)

Therapeutic Potential of Phytocannabinoid Cannabigerol for Multiple Sclerosis: Modulation of Microglial Activation In Vitro and In Vivo
por: Fleisher-Berkovich, Sigal, et al.
Publicado: (2023)

Telmisartan Modulates Glial Activation: In Vitro and In Vivo Studies
por: Torika, Nofar, et al.
Publicado: (2016)

Computational Simulations to Guide Enzyme-Mediated Prodrug Activation
por: Markovic, Milica, et al.
Publicado: (2020)

Prodrugs for Improved Drug Delivery: Lessons Learned from Recently Developed and Marketed Products
por: Markovic, Milica, et al.
Publicado: (2020)

Modern Prodrug Design for Targeted Oral Drug Delivery
por: Dahan, Arik, et al.
Publicado: (2014)

Anticancer activity of Nigella sativa (black seed) and its relationship with the thermal processing and quinone composition of the seed
por: Agbaria, Riad, et al.
Publicado: (2015)

Antiviral effect of phytochemicals from medicinal plants: Applications and drug delivery strategies
por: Ben-Shabat, Shimon, et al.
Publicado: (2019)

The Fundamental Role of Lipids in Polymeric Nanoparticles: Dermal Delivery and Anti-Inflammatory Activity of Cannabidiol
por: Zamansky, Mark, et al.
Publicado: (2023)

Lipids and Lipid-Processing Pathways in Drug Delivery and Therapeutics
por: Markovic, Milica, et al.
Publicado: (2020)

Prospects and Challenges of Phospholipid-Based Prodrugs
por: Markovic, Milica, et al.
Publicado: (2018)

Molecular Modeling-Guided Design of Phospholipid-Based Prodrugs
por: Markovic, Milica, et al.
Publicado: (2019)

Cannabidiol-Loaded Lipid-Stabilized Nanoparticles Alleviate Psoriasis Severity in Mice: A New Approach for Improved Topical Drug Delivery
por: Zamansky, Mark, et al.
Publicado: (2023)

Involvement of the Bradykinin B(1) Receptor in Microglial Activation: In Vitro and In Vivo Studies
por: Asraf, Keren, et al.
Publicado: (2017)

Cannabidiol-Loaded Nanoparticles Based on Crosslinked Starch: Anti-Inflammatory Activity and Improved Nose-to-Brain Delivery
por: Eydelman, Ilya, et al.
Publicado: (2023)

Medicinal Properties of Lilium candidum L. and Its Phytochemicals
por: Zaccai, Michele, et al.
Publicado: (2020)

Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities
por: Saavedra, Juan M.
Publicado: (2020)

Microglial Activation Is Modulated by Captopril: in Vitro and in Vivo Studies
por: Asraf, Keren, et al.
Publicado: (2018)

Glial Cells and Their Contribution to the Mechanisms of Action of Cannabidiol in Neuropsychiatric Disorders
por: Scarante, Franciele F., et al.
Publicado: (2021)

Phospholipid-Based Prodrugs for Colon-Targeted Drug Delivery: Experimental Study and In-Silico Simulations
por: Markovic, Milica, et al.
Publicado: (2019)

Fixed-Dose Combinations of Renin–Angiotensin System Inhibitors and Calcium Channel Blockers in the Treatment of Hypertension: A Comparison of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors
por: Hsiao, Fu-Chih, et al.
Publicado: (2015)

Calcineurin and glial signaling: neuroinflammation and beyond
por: Furman, Jennifer L, et al.
Publicado: (2014)

Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan
por: Omboni, Stefano, et al.
Publicado: (2018)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Neuroinflammation and glial cell activation in mental disorders
por: Almeida, Priscila G.C., et al.
Publicado: (2019)

Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
por: Al-Ghraiybah, Nour F., et al.
Publicado: (2022)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

What is the role of angiotensin receptor blockers in treatment of hyperuricemia coexisting with arterial hypertension?
por: Nieradko-Iwanicka, Barbara
Publicado: (2018)

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment
por: Pandya, Nischal R., et al.
Publicado: (2018)

Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment
por: Rasmussen, Eva Rye, et al.
Publicado: (2020)

Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA(2)-Mediated Activation
por: Markovic, Milica, et al.
Publicado: (2022)

Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging
por: Rodriguez-Perez, Ana I., et al.
Publicado: (2016)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Efficacy and Mechanism of Angiotensin II Receptor Blocker Treatment in Experimental Abdominal Aortic Aneurysms
por: Iida, Yasunori, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0tacfa4hv7v1fncnanvs4qibm4